GSK plc GSK.BA Stock
GSK plc Price Chart
GSK plc GSK.BA Financial and Trading Overview
| GSK plc stock price | 10635 ARS |
| Previous Close | 4305.5 ARS |
| Open | 4427.5 ARS |
| Bid | 4464 ARS x N/A |
| Ask | 4979 ARS x N/A |
| Day's Range | 4409 - 4472.5 ARS |
| 52 Week Range | 2171.5 - 4480 ARS |
| Volume | 134 ARS |
| Avg. Volume | 263 ARS |
| Market Cap | 36.63T ARS |
| Beta (5Y Monthly) | 0.307662 |
| PE Ratio (TTM) | 26.842516 |
| EPS (TTM) | 651.93 ARS |
| Forward Dividend & Yield | 80.67 (1.85%) |
| Ex-Dividend Date | May 18, 2023 |
| 1y Target Est | N/A |
GSK.BA Valuation Measures
| Enterprise Value | 8.74T ARS |
| Trailing P/E | 26.842516 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1259.4014 |
| Price/Book (mrq) | 766.62665 |
| Enterprise Value/Revenue | 300.374 |
| Enterprise Value/EBITDA | 906.168 |
Trading Information
GSK plc Stock Price History
| Beta (5Y Monthly) | 0.307662 |
| 52-Week Change | 35.60% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4480 ARS |
| 52 Week Low | 2171.5 ARS |
| 50-Day Moving Average | 4147.01 ARS |
| 200-Day Moving Average | 3176.46 ARS |
GSK.BA Share Statistics
| Avg. Volume (3 month) | 263 ARS |
| Avg. Daily Volume (10-Days) | 283 ARS |
| Shares Outstanding | 8.19B |
| Float | 1.96B |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.578 |
| Trailing Annual Dividend Yield | 0.013% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.55979997 |
| Last Split Factor | 4:5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 50.34% |
| Operating Margin (ttm) | 25.00% |
| Gross Margin | 70.34% |
| EBITDA Margin | 33.14% |
Management Effectiveness
| Return on Assets (ttm) | 6.13% |
| Return on Equity (ttm) | 28.17% |
Income Statement
| Revenue (ttm) | 29.08B ARS |
| Revenue Per Share (ttm) | 14.42 ARS |
| Quarterly Revenue Growth (yoy) | -3.30% |
| Gross Profit (ttm) | 19.92B ARS |
| EBITDA | 9.64B ARS |
| Net Income Avi to Common (ttm) | 4.46B ARS |
| Diluted EPS (ttm) | 166.62 |
| Quarterly Earnings Growth (yoy) | -17.29% |
Balance Sheet
| Total Cash (mrq) | 6.98B ARS |
| Total Cash Per Share (mrq) | 3.44 ARS |
| Total Debt (mrq) | 20.91B ARS |
| Total Debt/Equity (mrq) | 184.8 ARS |
| Current Ratio (mrq) | 0.953 |
| Book Value Per Share (mrq) | 5.834 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 4.91B ARS |
| Levered Free Cash Flow (ttm) | 3.25B ARS |
Profile of GSK plc
| Country | Argentina |
| State | N/A |
| City | Brentford |
| Address | 980 Great West Road |
| ZIP | TW8 9GS |
| Phone | 44 20 8047 5000 |
| Website | https://www.gsk.com |
| Industry | Drug Manufacturers-General |
| Sector(s) | Healthcare |
| Full Time Employees | 69400 |
GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.
Q&A For GSK plc Stock
What is a current GSK.BA stock price?
GSK plc GSK.BA stock price today per share is 10635 ARS.
How to purchase GSK plc stock?
You can buy GSK.BA shares on the Buenos Aires exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for GSK plc?
The stock symbol or ticker of GSK plc is GSK.BA.
Which industry does the GSK plc company belong to?
The GSK plc industry is Drug Manufacturers-General.
How many shares does GSK plc have in circulation?
The max supply of GSK plc shares is 8.17B.
What is GSK plc Price to Earnings Ratio (PE Ratio)?
GSK plc PE Ratio is 16.31310000 now.
What was GSK plc earnings per share over the trailing 12 months (TTM)?
GSK plc EPS is 651.93 ARS over the trailing 12 months.
Which sector does the GSK plc company belong to?
The GSK plc sector is Healthcare.